Device, Diagnostics Clinical Research
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
107
NCT03832426
A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers
Phase: Phase 1
Role: Collaborator
Start: Nov 8, 2013
Completion: Oct 24, 2014
NCT02200029
Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption
Phase: Phase 3
Start: Jun 30, 2014
Completion: Feb 28, 2015
Loading map...